{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:26:25Z","timestamp":1775136385342,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40123-026-01342-z","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:44:09Z","timestamp":1773341049000},"page":"1297-1312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quadrant-Specific Pain in Intravitreal Injection: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-9961","authenticated-orcid":false,"given":"Mehmet Cem","family":"Sabaner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irem","family":"Gunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Divarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Anguita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elon H. C.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ferro Desideri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse J\u00f8rgensen","family":"Cehofski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousif","family":"Subhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"issue":"4","key":"1342_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","volume":"239","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Told R, Sacu S, et al. 2018 update on intravitreal injections: Euretina expert consensus recommendations. Ophthalmologica. 2018;239(4):181\u201393. https:\/\/doi.org\/10.1159\/000486145.","journal-title":"Ophthalmologica"},{"issue":"1","key":"1342_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40123-020-00230-4","volume":"9","author":"AS Petri","year":"2020","unstructured":"Petri AS, Boysen K, Cehofski LJ, et al. Intravitreal injections with vascular endothelial growth factor inhibitors: a practical approach. Ophthalmol Ther. 2020;9(1):191\u2013203. https:\/\/doi.org\/10.1007\/s40123-020-00230-4.","journal-title":"Ophthalmol Ther"},{"issue":"7","key":"1342_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/IAE.0b013e3181a94f01","volume":"29","author":"GA Peyman","year":"2009","unstructured":"Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina. 2009;29(7):875\u2013912. https:\/\/doi.org\/10.1097\/IAE.0b013e3181a94f01.","journal-title":"Retina"},{"issue":"2","key":"1342_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/02713683.2022.2119254","volume":"48","author":"D Mishra","year":"2023","unstructured":"Mishra D, Gade S, Glover K, Sheshala R, Singh TRR. Vitreous humor: composition, characteristics and implication on intravitreal drug delivery. Curr Eye Res. 2023;48(2):208\u201318. https:\/\/doi.org\/10.1080\/02713683.2022.2119254.","journal-title":"Curr Eye Res"},{"issue":"1","key":"1342_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010108","volume":"2021","author":"HM Kim","year":"2021","unstructured":"Kim HM, Woo SJ. Ocular drug delivery to the retina: current innovations and future perspectives. Pharmaceutics. 2021;2021(1):108. https:\/\/doi.org\/10.3390\/pharmaceutics13010108.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1342_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41433-018-0208-y","volume":"33","author":"S Karimi","year":"2019","unstructured":"Karimi S, Mosavi SA, Jadidi K, Nikkhah H, Kheiri B. Which quadrant is less painful for intravitreal injection? A prospective study. Eye Lond. 2019;33(2):304\u201312. https:\/\/doi.org\/10.1038\/s41433-018-0208-y.","journal-title":"Eye Lond"},{"issue":"1","key":"1342_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5301\/ejo.5001001","volume":"28","author":"S Doguizi","year":"2018","unstructured":"Doguizi S, Sekeroglu MA, Inanc M, Anayol MA, Yilmazbas P. Evaluation of pain during intravitreal aflibercept injections. Eur J Ophthalmol. 2018;28(1):63\u20137. https:\/\/doi.org\/10.5301\/ejo.5001001.","journal-title":"Eur J Ophthalmol"},{"issue":"9","key":"1342_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3109\/02713683.2012.681335","volume":"37","author":"E Moisseiev","year":"2012","unstructured":"Moisseiev E, Regenbogen M, Bartfeld Y, Barak A. Evaluation of pain in intravitreal bevacizumab injections. Curr Eye Res. 2012;37(9):813\u20137. https:\/\/doi.org\/10.3109\/02713683.2012.681335.","journal-title":"Curr Eye Res"},{"issue":"6","key":"1342_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3341\/jkos.2016.57.6.930","volume":"57","author":"KD Jeong","year":"2016","unstructured":"Jeong KD, Kim JH, Kim JS, Hwang JH. Relationship between pain and injection site during intravitreal injection. J Korean Ophthalmol Soc. 2016;57(6):930\u20134. https:\/\/doi.org\/10.3341\/jkos.2016.57.6.930.","journal-title":"J Korean Ophthalmol Soc"},{"key":"1342_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.7197\/cmj.vi.540726","volume":"41","author":"\u00d6 G\u00fcler","year":"2019","unstructured":"G\u00fcler \u00d6, Urfal\u0131o\u011flu S, G\u00fcler M. The effect of intravitreal injection into different quadrants on pain score. Cumhur Med J. 2019;41:653\u20137. https:\/\/doi.org\/10.7197\/cmj.vi.540726.","journal-title":"Cumhur Med J"},{"key":"1342_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.52206\/jsmc.2022.12.4.737","volume":"12","author":"I Khan","year":"2022","unstructured":"Khan I, Zaib HMJ, Khalid A, et al. Comparison of pain in different quadrants while giving intravitreal injection. J Saidu Med Coll Swat. 2022;12:161\u20138. https:\/\/doi.org\/10.52206\/jsmc.2022.12.4.737.","journal-title":"J Saidu Med Coll Swat"},{"issue":"3","key":"1342_CR12","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1111\/aos.12531","volume":"93","author":"N Massamba","year":"2015","unstructured":"Massamba N, Elluard M, Agoune W, et al. Assessment of ocular pain following ranibizumab intravitreal injection. Acta Ophthalmol. 2015;93(3):e231\u20132. https:\/\/doi.org\/10.1111\/aos.12531.","journal-title":"Acta Ophthalmol"},{"key":"1342_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/njo.njo_22_18","volume":"27","author":"O Onakpoya","year":"2019","unstructured":"Onakpoya O, Akinwande J. Evaluation of ocular pain during and after intravitreal injection of antivascular endothelial growth factors in South-West Nigeria. Niger J Ophthalmol. 2019;27:1\u20137. https:\/\/doi.org\/10.4103\/njo.njo_22_18.","journal-title":"Niger J Ophthalmol"},{"issue":"8","key":"1342_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/eye.2014.129","volume":"28","author":"E Moisseiev","year":"2014","unstructured":"Moisseiev E, Regenbogen M, Rabinovitch T, Barak A, Loewenstein A, Goldstein M. Evaluation of pain during intravitreal Ozurdex injections vs. intravitreal bevacizumab injections. Eye Lond. 2014;28(8):980\u20135. https:\/\/doi.org\/10.1038\/eye.2014.129.","journal-title":"Eye Lond"},{"key":"1342_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2147\/OPTH.S223530","volume":"14","author":"J Han","year":"2020","unstructured":"Han J, Rinella NT, Chao DL. Anesthesia for intravitreal injection: a systematic review. Clin Ophthalmol. 2020;14:543\u201350. https:\/\/doi.org\/10.2147\/OPTH.S223530.","journal-title":"Clin Ophthalmol"},{"key":"1342_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1213\/01.ane.0000492895.92669.57","volume":"123","author":"AK Takaschima","year":"2016","unstructured":"Takaschima AK, Shiroma H, Canto GDL, Rodrigues E. Evaluation of different anesthetic techniques for intravitreal injection of antiangiogenics and steroids: a systematic review. Anesth Analg. 2016;123:649\u201350. https:\/\/doi.org\/10.1213\/01.ane.0000492895.92669.57.","journal-title":"Anesth Analg"},{"issue":"7","key":"1342_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1517\/17425247.2012.685156","volume":"9","author":"J Gambrell","year":"2012","unstructured":"Gambrell J, Schaal S. Topical anesthesia for intravitreal injection. Expert Opin Drug Deliv. 2012;9(7):731\u20133. https:\/\/doi.org\/10.1517\/17425247.2012.685156.","journal-title":"Expert Opin Drug Deliv"},{"key":"1342_CR18","unstructured":"Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. www.training.cochrane.org\/handbook. Accessed 30 Oct 2025."},{"key":"1342_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"6","key":"1342_CR20","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805. https:\/\/doi.org\/10.1177\/0962280216669183.","journal-title":"Stat Methods Med Res"},{"key":"1342_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111370","volume":"171","author":"E Tomlinson","year":"2024","unstructured":"Tomlinson E, Cooper C, Davenport C, et al. Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies. J Clin Epidemiol. 2024;171:111370. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111370.","journal-title":"J Clin Epidemiol"},{"key":"1342_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3341\/kjo.2017.0081","volume":"32","author":"SH Shin","year":"2018","unstructured":"Shin SH, Park SP, Kim Y-K. Factors associated with pain following intravitreal injections. Korean J Ophthalmol. 2018;32:196. https:\/\/doi.org\/10.3341\/kjo.2017.0081.","journal-title":"Korean J Ophthalmol"},{"key":"1342_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/joco.joco_6_21","volume":"33","author":"A Inaltekin","year":"2021","unstructured":"Inaltekin A, Bozkurt E, K\u0131vrak Y. Factors associated with pain level in patients receiving intravitreal injection. J Curr Ophthalmol. 2021;33:323\u20139. https:\/\/doi.org\/10.4103\/joco.joco_6_21.","journal-title":"J Curr Ophthalmol"},{"issue":"6","key":"1342_CR24","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00417-021-05422-7","volume":"260","author":"LM Wasser","year":"2022","unstructured":"Wasser LM, Roditi E, Weiss AR, et al. Anxiety and pain perception using a speculum-free eyelid retraction technique for intravitreal injection. Graefes Arch Clin Exp Ophthalmol. 2022;260(6):2023\u20138. https:\/\/doi.org\/10.1007\/s00417-021-05422-7.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"1342_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.ophtha.2018.01.038","volume":"125","author":"H Sasajima","year":"2018","unstructured":"Sasajima H, Tsuboi K, Ono H, Murotani K, Kamei M. A randomized trial of a short 34-gauge needle for intravitreal injections. Ophthalmology. 2018;125(6):947\u20138. https:\/\/doi.org\/10.1016\/j.ophtha.2018.01.038.","journal-title":"Ophthalmology"},{"issue":"6","key":"1342_CR26","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1177\/1120672120902026","volume":"30","author":"MM Reynolds","year":"2020","unstructured":"Reynolds MM, Mercill SL, Wirkus AL, Greenwood Quaintance K, Pulido JS. Topical proparacaine eye drops to improve the experience of patients undergoing intravitreal injections: a randomized controlled trial. Eur J Ophthalmol. 2020;30(6):1454\u201360. https:\/\/doi.org\/10.1177\/1120672120902026.","journal-title":"Eur J Ophthalmol"},{"key":"1342_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100862","volume":"80","author":"GB Melo","year":"2021","unstructured":"Melo GB, Cruz NFSD, Emerson GG, et al. Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections. Prog Retin Eye Res. 2021;80:100862. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100862.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"1342_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/IAE.0b013e3182252ad3","volume":"32","author":"L Rifkin","year":"2012","unstructured":"Rifkin L, Schaal S. Factors affecting patients\u2019 pain intensity during in office intravitreal injection procedure. Retina. 2012;32(4):696\u2013700. https:\/\/doi.org\/10.1097\/IAE.0b013e3182252ad3.","journal-title":"Retina"},{"issue":"5","key":"1342_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/cxo.12974","volume":"103","author":"E Ertan","year":"2020","unstructured":"Ertan E, Duman R, Duman R. Comparison of pain during intravitreal dexamethasone, ranibizumab and aflibercept injection. Clin Exp Optom. 2020;103(5):630\u20133. https:\/\/doi.org\/10.1111\/cxo.12974.","journal-title":"Clin Exp Optom"},{"issue":"3","key":"1342_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s40123-023-00879-7","volume":"13","author":"ETS Butler","year":"2024","unstructured":"Butler ETS, Bjerager J, Eriksen NS, et al. Effect of needle gauge size on pain during intravitreal anti-VEGF injection: a systematic review and network meta-analysis. Ophthalmol Ther. 2024;13(3):801\u201317. https:\/\/doi.org\/10.1007\/s40123-023-00879-7.","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"1342_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/aos.12901","volume":"94","author":"P Haas","year":"2016","unstructured":"Haas P, Falkner-Radler C, Wimpissinger B, Malina M, Binder S. Needle size in intravitreal injections - pain evaluation of a randomized clinical trial. Acta Ophthalmol. 2016;94(2):198\u2013202. https:\/\/doi.org\/10.1111\/aos.12901.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1342_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5935\/0004-2749.20150008","volume":"78","author":"GC Andrade","year":"2015","unstructured":"Andrade GC, Carvalho AC. Comparison of 3 different anesthetic approaches for intravitreal injections: a prospective randomized trial. Arq Bras Oftalmol. 2015;78(1):27\u201331. https:\/\/doi.org\/10.5935\/0004-2749.20150008.","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"1342_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/IAE.0b013e3181eac724","volume":"31","author":"GR Blaha","year":"2011","unstructured":"Blaha GR, Tilton EP, Barouch FC, Marx JL. Randomized trial of anesthetic methods for intravitreal injections. Retina. 2011;31(3):535\u20139. https:\/\/doi.org\/10.1097\/IAE.0b013e3181eac724.","journal-title":"Retina"},{"key":"1342_CR34","doi-asserted-by":"publisher","DOI":"10.5935\/2595-0118.20210039","author":"KOCA Santos","year":"2021","unstructured":"Santos KOCA, Dias EF, da Santos MS, Ribeiro CJN, do de Ribeiro MO. Pain management during intravitreal injection: integrative review. Braz J Pain. 2021. https:\/\/doi.org\/10.5935\/2595-0118.20210039.","journal-title":"Braz J Pain"},{"issue":"1","key":"1342_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-024-03315-2","volume":"44","author":"S Voichanski","year":"2024","unstructured":"Voichanski S, Totah H, Hanhart J. Pain perception during intravitreal injections is related to the timing of instilling anesthetic eyedrops. Int Ophthalmol. 2024;44(1):383. https:\/\/doi.org\/10.1007\/s10792-024-03315-2.","journal-title":"Int Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01342-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01342-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01342-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:42:19Z","timestamp":1775133739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01342-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01342-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mehmet Cem Sabaner is an Advisory Editorial Board member of\n                      Ophthalmology and Therapy\n                      . Mehmet Cem Sabaner was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decision. Irem Gunes has nothing to disclose. Abdullah Divarci has nothing to disclose. Rodrigo Anguita is an Editorial Board member of\n                      Ophthalmology and Therapy\n                      . Rodrigo Anguita was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decision. Elon H.C. van Dijk has nothing to disclose. Lorenzo Ferro Desideri has nothing to disclose. Lasse J\u00f8rgensen Cehofski has nothing to disclose. Yousif Subhi is an Editorial Board member of\n                      Ophthalmology and Therapy\n                      . Yousif Subhi was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decision. None of the authors were involved in the selection of reviewers or any editorial decisions regarding this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This systematic review and meta-analysis uses data from previously conducted studies and does not report any new data from studies conducted in human participants by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}